Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Greater Collaboration and Access to Data can Help Tackle Rare Diseases

Posted on November 1st, 2018 by in Pharma R&D

It is estimated that 30 million people in the United States alone are living with one of 7,000 rare diseases, this equates to 10% of the population. There is, however, little financial incentive for the pharmaceutical sector to develop new treatments for these diseases because of the small patient population each disease affects. Continue reading “How Greater Collaboration and Access to Data can Help Tackle Rare Diseases” »

How Drug Repurposing Is Revitalizing the Pharma Industry

Posted on October 16th, 2018 by in Pharma R&D

The average expense of bringing a new drug to market has increased by more than 200 percent since the 1990s, with development costs regularly running into the billions. As pharma revenues continue to sink below the costs of creating commercially viable drugs, a growing number of developers are exploring a different approach: seeking out additional monetizable uses for drugs to which they already own intellectual property rights. Continue reading “How Drug Repurposing Is Revitalizing the Pharma Industry” »

Advantages and Challenges of Using Social Media for Pharma R&D

Posted on July 7th, 2017 by in Pharma R&D

Social media is a force to be reckoned with in modern society. Over the last decade, it has changed the way we interact with friends and family, consumes news and entertainment, and do business.

Continue reading “Advantages and Challenges of Using Social Media for Pharma R&D” »